GlucoTrack, OneTwo Analytics collaborate to study analysis on CBG Monitor

Glucotrack (GCTK) announced an agreement with OneTwo Analytics AB. Through this collaboration, Glucotrack will leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its Continuous Blood Glucose, CBG, Monitor, enhancing insights into its performance and clinical value. “OneTwo Analytics are experts in simplifying complex diabetes data to generate simple, clear insights empowering clinics, healthcare professionals, and individuals with diabetes to make better informed decisions. We are excited to leverage their substantial analytics experience to identify, assess and quantify the potential long-term benefits of the CBGM technology,” stated Paul V. Goode, PhD, President and Chief Executive Officer of Glucotrack. “We are committed to building on our robust suite of preclinical and in silico data by utilizing their comprehensive analytical and AI assessment tools, thereby ensuring our ability to deliver a disruptive, high-quality glucose monitoring solution to people with diabetes.”